Treatment of Acute Central Serous Chorioretinopathy with Micropulsed Yellow Laser
Keywords:
acute central serous chorioretinopathy; micro-pulsed yellow laser; central macular thickness; subfoveal fluid heightAbstract
Objective: To determine the structural and functional outcomes of patients with acute central serous chorioretinopathy treated with 577 nm micro-pulsed yellow laser at the Retina Service of the “Ramón Pando Ferrer” Cuban Institute of Ophthalmology.
Methods: Specific tests were performed on each patient, and their medical records were reviewed. A descriptive, longitudinal, and prospective study was conducted on 30 patients.
Results: The average age was 39.67 years; males predominated (53.33%); and more than one risk factor was present in 70% of patients, with stress (70%) and sleep disorders (46.7%) being the most common. Six weeks post-treatment, baseline visual acuity ranged from 0.24 ± 0.14 logMAR to 0.06 ± 0.08 logMAR. The initial mean central foveal thickness (418.3 µm) decreased to 229.7 µm. Favorable changes were observed in the structural recovery of the foveal center and best-corrected visual acuity in more than 50% of patients, as well as improvement in pigment epithelium irregularities and fibrin in the subretinal fluid.
Conclusions: Treatment with a 577-nm micro-pulsed yellow laser is a beneficial option for treating acute central serous chorioretinopathy because it improves foveal structure and enables visual recovery in patients.
Downloads
References
1. Kanda P, Gupta A, Gottlieb C, Karanjia R, Coupland S, Bal M. Pathophysiology of Central Serous Chorioretinopathy: a Literature Review with Quality Assessment. Eye (Lond). 2022;36(5):941-62. DOI: https://doi.org/10.1038/s41433-021-01808-3
2. Van Rijssen T, van Dijk E, Scholz P, Breukink M, Dijkman G, Peters P, et al. Long-Term Follow-Up of Chronic Central Serous Chorioretinopathy after Successful Treatment with Photodynamic Therapy or Micropulse Laser. Acta Ophthalmol. 2021;99(7):805-11. DOI: https://doi.org/10.1111/aos.14775
3. Ryan S, Sadda S, Wilkinson C, Wiedemann P, Schachat A. Ryan's retina. 7 ed. En: Central serous chorioretinopathy. Londres: Elevier; 2023 [acceso 03/02/2025];(2)1:251-1309. Disponible en: https://shop.elsevier.com/books/ryans-retina/sadda/978-0-323-72213-1
4. Fung A, Yang Y, Kam A. Central serous chorioretinopathy: A review. Clin Exp Ophthalmol. 2023;51(3):243-70. DOI: https://doi.org/10.1111/ceo.14201
5. Xu F, Wan C, Zhao L, Liu S, Hong J, Xiang Y, et al. Predicting Post-Therapeutic Visual Acuity and OCT Images in Patients with Central Serous Chorioretinopathy by Artificial Intelligence. Front Bioeng Biotechnol. 2021;23;9:649221. DOI: https://doi.org/10.3389/fbioe.2021.649221.
6. Mccannel C, European Board Of Ophthalmology, American Academy of Ophthalmology. Retina and Vitreous. San Francisco, Ca: American Academy of Ophthalmology; 2018 [acceso 03/02/2025]. Disponible en: https://www.amazon.com/-/es/American-Academy-Ophthalmology/dp/1681040387
7. Semeraro F, Morescalchi F, Russo A, Gambicorti E, Pilotto A, Parmeggiani F, et al. Central Serous Chorioretinopathy: Pathogenesis and Management. Clin Ophthalmol. 2019;13:2341-52. DOI: https://doi.org/10.2147/OPTH.S220845
8. Fernando J, Agüero A, Arzabe W, Lavaque A, Ramón N, Roca A, et al. Retina 2019. PAAO; 2019 [acceso 03/02/2025]. Disponible en: https://paao.org/wp-content/uploads/2016/05/LIBRO-RETINA-PAAO-2019-interactivo.pdf
9. Jain M, Mohan S, van Dijk E. Central Serous Chorioretinopathy: Pathophysiology, Systemic Associations, and a Novel Etiological Classification. Taiwan J Ophthalmol. 2022;12(4):381-93. DOI: https://doi.org/10.4103/2211-5056.362601
10. Yannuzzi. Central Serous Chorioretinopathy: A Personal Perspective. Am J Ophthalmol. 2010;149(3):361-3. DOI: https://doi.org/10.1016/j.ajo.2009.11.017
11. Romano M, Parolini B, Allegrini D, Michalewska Z, Adelman R, Bonovas S, et al. EVRS Study Group. An International Collaborative Evaluation of Central Serous Chorioretinopathy: Different Therapeutic Approaches and Review of Literature. The European Vitreoretinal Society Central Serous Chorioretinopathy Study. Acta Ophthalmol. 2020;98(5):e549-e558. DOI: https://doi.org/10.1111/aos.14319
12. Salehi M, Wenick A, Law H, Evans J, Gehlbach P. Interventions for Central Serous Chorioretinopathy: A Network Meta-Analysis. Cochrane Database Syst Rev. 2015;5(12):CD011841. DOI: https://doi.org/10.1002/14651858.CD011841.
13. Zhao G, Li R, Pang Y, Wang X, Wei J, Zhou Z. Diagnostic Value Of 3D Optical Coherence Tomography Multimode Images in the Diagnosis of Acute Central Serous Chorioretinopathy. Curr Med Imaging. 2023. DOI: https://doi.org/10.2174/1573405620666230804093929
14. Pradhan A, Behera U. Comparison of Prevalent Management Options to Treat Acute Central Serous Chorioretinopathy. Indian J Ophthalmol. 2023;71(11):3563-8. DOI: https://doi.org/10.4103/IJO.IJO_677_23
15. Nicholson B, Noble J, Forooghian F, Meyerle C. Central Serous Chorioretinopathy: Update on Pathophysiology and Treatment. Surv Ophthalmol. 2013;58(2):103-26. DOI: https://doi.org/10.1016/j.survophthal.2012.07.004
16. Victor A, Djatikusumo A, Yudantha A Suryoadji K. Wait-and-See and other Factors Associated with Recurrence Risk in Central Serous Chorioretinopathy Patients: A Systematic Review and Meta-Analysis of Cohort Studies. F1000Research. 2023;12:1036 DOI: https://doi.org/10.12688/f1000research.138162.1
17. Gawęcki M, Jaszczuk-Maciejewska A, Jurska-Jaśko A, Grzybowski A. Functional and Morphological Outcome in Patients with Chronic Central Serous Chorioretinopathy Treated by Subthreshold Micropulse Laser. Graefes Arch Clin Exp Ophthalmol. 2017;255(12):2299-306. DOI: https://doi.org/10.1007/s00417-017-3783-x
18. Daniel W, Cross C. Biostatistics: A Foundation for Analysis in the Health Sciences. Hoboken, Nj: Wiley; 2019 [acceso 03/02/2025]. Disponible en: https://www.wiley.com/en-us/Biostatistics%3A+A+Foundation+for+Analysis+in+the+Health+Sciences%2C+11th+Edition-p-9781119496571
19. Cardillo J, Chong V, Mansour S. Fovea-friendly MicroPulse Laser. En: Retina Today; 2012 [acceso 03/02/2025]. Disponible en: https://www.iridex.com/Portals/0/physician-education/pdf/Fovea-friendly%20Suppl,%20RT%202012.pdf
20. Alvarado A. Evaluación anatomofuncional de pacientes con coroidoretinopatía serosa central aguda [Tesis]. Universidad De Ciencias Médicas de La Habana. Instituto Cubano de Oftalmología “Ramon Pando Ferrer”; 2019.
21. Arora S, Sridharan P, Arora T, Chhabra M, Ghosh B. Subthreshold Diode Micropulse Laser Versus Observation in Acute Central Serous Chorioretinopathy. Clin Exp Optom. 2019;102(1):79-85. DOI: https://doi.org/10.1111/cxo.12818.
22. Roca J, Wu L, Fromow-Guerra J, Rodríguez F, Berrocal M, Rojas S, et al. Yellow (577 nm) Micropulse Laser versus Half-Dose Verteporfin Photodynamic Therapy in Eyes with Chronic Central Serous Chorioretinopathy: Results of the Pan-American Collaborative Retina Study (PACORES) Group. Br J Ophthalmol. 2018;102(12):1696-700. DOI: https://doi.org/10.1136/bjophthalmol-2017-311291
23. Liu B, Deng T, Zhang J. Risk Factors for Central Serous Chorioretinopathy: A Systematic Review and Meta-Analysis. Retina. 2016;36(1):9-19. DOI: https://doi.org/10.1097/IAE.0000000000000837
24. Zhou L, Chong V, Lai K, Huang C, Xu F, Gong Y, et al. A Pilot Prospective Study of 577-Nm Yellow Subthreshold Micropulse Laser Treatment with two Different Power Settings for Acute Central Serous Chorioretinopathy. Lasers Med Sci. 2019;34(7):1345-51. DOI: https://doi.org/10.1007/s10103-019-02721-8
25. Sun Z, Huang Y, Nie C, Wang Z, Pei J, Lin B, et al. Efficacy and Safety of Subthreshold Micropulse Laser Compared with Threshold Conventional Laser in Central Serous Chorioretinopathy. Eye (Lond). 2020;34(9):1592-99. DOI: https://doi.org/10.1038/s41433-019-0692-8
26. Spaide R, Campeas L, Haas A, Yannuzzi L, Fisher Y, Guyer D, et al. Central Serous Chorioretinopathy in Younger and Older Adults. Ophthalmology. 1996;103(12):2070-9. DOI: https://doi.org/10.1016/s0161-6420(96)30386-2
27. Long H, Liu M, Hu Q, Li X. 577 nm Subthreshold Micropulse Laser Treatment for Acute Central Serous Chorioretinopathy: A Comparative Study. BMC Ophthalmol. 2022;22(1):105. DOI: https://doi.org/10.1186/s12886-022-02330-0
28. Gawęcki M, Jaszczuk-Maciejewska A, Jurska-Jaśko A, Grzybowski A. Functional and Morphological Outcome in Patients with Chronic Central Serous Chorioretinopathy Treated by Subthreshold Micropulse Laser. Graefes Arch Clin Exp Ophthalmol. 2017;255(12):2299-306. DOI: https://doi.org/10.1007/s00417-017-3783-x
29. Abd A. Subthreshold Micropulse Yellow Laser Treatment for Nonresolving Central Serous Chorioretinopathy. Clin Ophthalmol. 2015;9:2277-83. DOI: https://doi.org/10.2147/OPTH.S87499
30. Ojima Y, Tsujikawa A, Yamashiro K, Ooto S, Tamura H, Yoshimura N. Restoration of Outer Segments of Foveal Photoreceptors after Resolution of Central Serous Chorioretinopathy. Jpn J Ophthalmol. 2010;54(1):55-60. DOI: https://doi.org/10.1007/s10384-009-0766-4
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Revista Cubana de Oftalmología
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
El contenido de la revista se encuentra accesible sin costo alguno. Está protegido por los términos de la Licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional
